BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu W, Hu C, Gao H. Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages. Adv Drug Deliv Rev 2021;178:113909. [PMID: 34352354 DOI: 10.1016/j.addr.2021.113909] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Mao D, Wang H, Che X, Chen Y. Formation of pre-metastatic niches induced by tumor extracellular vesicles in lung metastasis. Pharmacol Res 2023;188:106669. [PMID: 36681367 DOI: 10.1016/j.phrs.2023.106669] [Reference Citation Analysis]
2 Hegde M, Naliyadhara N, Unnikrishnan J, Alqahtani MS, Abbas M, Girisa S, Sethi G, Kunnumakkara AB. Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives. Cancer Lett 2023;556:216066. [PMID: 36649823 DOI: 10.1016/j.canlet.2023.216066] [Reference Citation Analysis]
3 Ren D, Cheng Y, Xu W, Qin W, Hao T, Wang F, Hu Y, Ma L, Zhang C. Copper-Based Metal-Organic Framework Induces NO Generation for Synergistic Tumor Therapy and Antimetastasis Activity. Small 2023;19:e2205772. [PMID: 36424140 DOI: 10.1002/smll.202205772] [Reference Citation Analysis]
4 Zhu Y, Zhou X, Yao Z. A mini-review: Advances in plant-derived extracellular vesicles as nano-delivery systems for tumour therapy. Front Bioeng Biotechnol 2022;10:1076348. [PMID: 36588940 DOI: 10.3389/fbioe.2022.1076348] [Reference Citation Analysis]
5 Malacrida A, Erriquez J, Hashemi M, Rodriguez-menendez V, Cassetti A, Cavaletti G, Miloso M. Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells. Biochemistry and Biophysics Reports 2022;32:101353. [DOI: 10.1016/j.bbrep.2022.101353] [Reference Citation Analysis]
6 Mansoori-Kermani A, Khalighi S, Akbarzadeh I, Niavol FR, Motasadizadeh H, Mahdieh A, Jahed V, Abdinezhad M, Rahbariasr N, Hosseini M, Ahmadkhani N, Panahi B, Fatahi Y, Mozafari M, Kumar AP, Mostafavi E. Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer. Mater Today Bio 2022;16:100349. [PMID: 35875198 DOI: 10.1016/j.mtbio.2022.100349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Li M, Zhang Y, Zhang Q, Li J. Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines. Mater Today Bio 2022;16:100364. [PMID: 35875197 DOI: 10.1016/j.mtbio.2022.100364] [Reference Citation Analysis]
8 Yu X, Wang H, Liu X, Huang L, Song N, Song Y, Mo X, Lou S, Shi L, Yu Z. Assembling synergistic peptide-drug conjugates for dual-targeted treatment of cancer metastasis. Nano Today 2022;46:101594. [DOI: 10.1016/j.nantod.2022.101594] [Reference Citation Analysis]
9 Zeng L, Shi W, Wang H, Cheng X, Chen T, Wang LL, Lan J, Sun W, Liu M, Zhang X, Zhang J, Chen J. Codelivery of π-π Stacked Dual Anticancer Drugs Based on Aloe-Derived Nanovesicles for Breast Cancer Therapy. ACS Appl Mater Interfaces 2022;14:27686-702. [PMID: 35675505 DOI: 10.1021/acsami.2c06546] [Reference Citation Analysis]
10 Lu Q, Ye H, Wang K, Zhao J, Wang H, Song J, Fan X, Lu Y, Cao L, Wan B, Zhang H, He Z, Sun J. Bioengineered Platelets Combining Chemotherapy and Immunotherapy for Postsurgical Melanoma Treatment: Internal Core-Loaded Doxorubicin and External Surface-Anchored Anti-PD-L1 Antibody Backpacks. Nano Lett 2022. [PMID: 35318846 DOI: 10.1021/acs.nanolett.2c00907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jia W, Liu R, Wang Y, Hu C, Yu W, Zhou Y, Wang L, Zhang M, Gao H, Gao X. Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 das Neves J, Ensign L. Advances in drug delivery for women's health: A matter of gender equity. Adv Drug Deliv Rev 2022;182:114132. [PMID: 35090956 DOI: 10.1016/j.addr.2022.114132] [Reference Citation Analysis]
13 Zhang L, Zhu Y, Wei X, Chen X, Li Y, Zhu Y, Xia J, Huang Y, Huang Y, Wang J, Pang Z. Nanoplateletsomes restrain metastatic tumor formation through decoy and active targeting in a preclinical mouse model. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.01.005] [Reference Citation Analysis]
14 Li B, Tan T, Chu W, Zhang Y, Ye Y, Wang S, Qin Y, Tang J, Cao X. Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy. Drug Delivery 2022;29:75-88. [DOI: 10.1080/10717544.2021.2018523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhu D, Li A, Di Y, Wang Z, Shi J, Ni X, Wang Y. Interference-free SERS nanoprobes for labeling and imaging of MT1-MMP in breast cancer cells. Nanotechnology 2021;33. [PMID: 34874311 DOI: 10.1088/1361-6528/ac4065] [Reference Citation Analysis]
16 Nizamuddin I, Cristofanilli M. Understanding metastasis in breast cancer to improve detection, monitoring and treatment. Crit Rev Oncol Hematol 2021;167:103462. [PMID: 34534657 DOI: 10.1016/j.critrevonc.2021.103462] [Reference Citation Analysis]